Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Images of Hela cells expressing a live cell fluorescent mitosis biosensor as they go through cell division. The images start with a representative cell in G2, (upper left panel), and show examples of the localization of the biosensor in cells as they proceed through the mitotic stages, prometaphase, metaphase, anaphase, telophase, and cytokinesis. (See Meyer and colleagues, p 306). Image courtesy of Joshua Jones.
Developing countries could exploit traditional medicine to kick-start biotech, but only if their products measure up to the demands of Western regulators. Paroma Basu reports.
Before they fell into disfavor, legally independent affiliates of biotech companies—special purpose entities—had supported the development of several blockbuster drugs. Are they about to stage a comeback?
The successful immortalization of neural progenitor cells via the overexpression of telomerase prompts several questions for those intending to develop somatic stem cell therapies for neurological disease.
In light of the Japan Patent Office's revised examination guidelines, what are the potential problems of protecting advanced biomedical methods related to medical activity?